Progression of cutaneous B-cell pseudolymphoma to cutaneous B-cell lymphoma

Journal of Cutaneous Medicine and Surgery

Volumn 6, Issue 6, 2002, Pages 519-528

  Kulow, Brittain F ^a   Cualing, Hernani ^a   Steele, Paul ^a   VanHorn, Judi ^a   Breneman, John C ^a   Mutasim, Diya F ^a   Breneman, Debra L ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CLINICAL FEATURE; CUTANEOUS B CELL LYMPHOMA; CUTANEOUS B CELL PSEUDOLYMPHOMA; FOLLOW UP; GENE REARRANGEMENT; HISTOLOGY; HUMAN; IMMUNOPHENOTYPING; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOLYMPHOMA; SKIN LYMPHOMA; SOUTHERN BLOTTING;

ADULT; AGED; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PSEUDOLYMPHOMA; RETROSPECTIVE STUDIES; SKIN; SKIN DISEASES; SKIN NEOPLASMS; TIME FACTORS;

EID: 0036872237     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10227-001-0133-7     Document Type: Article

References (65)

1. Evans HL, Winkelmann RK, Banks PM. Differential diagnosis of malignant and benign cutaneous lymphoid infiltrates: a study of 57 cases in which malignant lymphoma has been diagnosed or suspected in this skin. Cancer 1979; 44:699-717.
2. Lange Wantzin G, Hou-Jensen K, Nielson M. Cutaneous lymphocytomas: Clinical and histological aspects. Acta Derm Venereol 1982; 62:119-124.
3. Caro WA, Helwig EB. Cutaneous lymphoid hyperplasia. Cancer 1969; 24:487-502.
4. MacDonald DM. Histopathological differentiation of benign and malignant cutaneous lymphocytic infiltrates. Br J Dermatol 1982; 107:715-718.
5. rd ed. Blackwell Scientific, Oxford pp 1529-1532.
6. Haynes HA, Van Scott EJ, (1979) Lymphomas. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF eds. Dermatology in General Medicine, 2nd ed. McGraw-Hill, New York pp 763-764.
7. Kerl H, Smolle J. Classification of cutaneous pseudolymphomas. Curr Probl Dermatol 1990; 19:167-175.
8. Levy R, Warnke RA, Dorfman RF. The monoclonality of human B-cell lymphomas. J Exp Med 1977; 145:1014-1028.
9. Winkelmann RK, Dabski K. Large cell lymphocytoma: Follow-up, immunopathologic studies and comparison to cutaneous follicular and Crosti lymphoma. Arch Dermatol Res 1987; 279:S81-S87.
10. Wirt D, Grogan T, Jolley C, et al. The immunoarchitecture of cutaneous pseudolymphoma. Hum Pathol 1985; 6:492-510.
11. Willemze R, Meijer CJLM, Sentis H, et al. Primary cutaneous large cell lymphomas of follicular center cell origin. J Am Acad Dermatol 1987; 16(3 Pt 1):518-526.
12. Santucci M, Pimpinelli N, Arganini L. Primary cutaneous B-cell lymphoma: A unique type of low-grade lymphoma. Clinicopathologic and immunologic study of 83 cases. Cancer 1991; 67:2311-2326.
13. Garcia C, Weiss L, Warnke R, et al. Cutaneous follicular lymphoma. Am J Surg Pathol 1986; 10:454-463.
14. Rijlaarsdam JU, Van der Putte SCJ. Berti EA et al. Cutaneous immunocytomas: A clinicopathologic study of 26 cases. Histopathology 1993; 23:117-125.
15. nd DM, Halper JP, Jakobiec FA. The immunologic characterization of 40 extranodal lymphoid infiltrates: usefulness indistinguishing between benign pseudolymphoma and malignant lymphoma. Cancer 1982; 49:2321-2335.
16. Medeiros W, Picker LJ, Abel EA, et al. Cutaneous lymphoid hyperplasia. Immunologic characteristics and assessment of criteria recently proposed as diagnostic of malignant lymphoma. J Am Acad Dermatol 1989; 21(5 pt 1):929-942.
17. Willemze R, Vermeer BJ, Meijer CJLM. Immunohistochemical studies in lymphocytic infiltration of the skin (Jessner) and discoid lupus erythematosus. J Am Acad Dermatol 1984; 11(5 pt 1):832-840.
18. Ralfkiaer E, Lange Wantzin G, Mason DY, et al. pharacterization of benign cutaneous lymphocytic infiltrates by monoclonal antibodies. Br J Dermatol 1984; 111:635-645.
19. Picker L, Weiss LM, Medeiros LJ, et al. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol 1987; 128:181-201.
20. Wood GS, Burke JS, Horning S, et al. The immunologic and clinicopathologic heterogeneity of cutaneous lymphomas other than mycosis fungoides. Blood 1983; 62:464-472.
21. Arnold A, Cossman J, Bakhshi A, et al. Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. N Engl J Med 1983; 309:1593-1599.
22. Wood GS, Ngan B, Tung R, et al. Clonal rearrangements of immunoglobulin genes and progression to B cell lymphoma in cutaneous lymphoid hyperplasia. Am J Pathol 1989; 135:13-19.
23. Rijlaarsdam U, Bakels V, Van Oostveen JW, et al. Demonstration of clonal immunoglobulin gene rearrangements in cutaneous B-cell lymphomas and pseudo-B-cell lymphomas: Differential diagnostic and pathogenetic aspects. J Invest Dermatol 1992; 99:749-754.
24. Hammer E, Sangueza O, Suwanjindar P, et al. Immunophenotypic and genotypic analysis in cutaneous lymphoid hyperplasias. J Am Acad Dermatol 1993; 28:426-433.
25. Wechsler J, Bagot M, Henni T, et al. Cutaneous pseudolymphomas: imunophenotypical and immungenotypical studies. Curr Prob Dermatol 1990; 19:183-188.
26. Griesser H, Feller AC, Sterry W. T-cell receptor and immunoglobulin gene rearrangements in cutaneous T-cell rich pseudolymphomas. J Invest Dermatol 1990; 95:292-295.
27. Shelley WB, Wood MG, Wilson JF, et al. Premalignant lymphoid hyperplasia. Arch Dermatol 1981; 117:500-503.
28. Slater DN. Cutaneous lymphoproliferative disorders: An assessment of recent investigative techniques. Br J Dermatol 1991; 124:309-323.
29. Rijlaarsdam JU, Willemze R. Cutaneous pseudolymphomas: classification and differential diagnosis. Semin Dermatol 1994; 13:187-196.
30. Allday MJ, Crawford DH. Role of epithelium in EBV persistence and pathogenesis of B-cell tumours. Lancet 1988; 1:855-857.
31. Van Hale HM, Winkelmann RK. Nodular lymphoid disease of the head and neck: lymphocytoma cutis, benign lymphocytic infiltrate of Jessner, and their distinction from malignant lymphoma. J Am Acad Dermatol 1985; 12:455-461.
32. Kneba M, Bolz I, Bergholz M, et al. Clinical characteristics of highgrade lymphomas with immune genes in germline configuration. Cancer 1991; 67:603-609.
33. Ploysangam T, Breneman DL, Mutasim DF. Cutaneous pseudolymphomas. J Am Acad Dermatol 1998; 38:877-905.
34. Landa NG, Zelickson BD, Peters MS. Cutaneous lymphoma versus pseudolymphoma: Gene rearrangement studies of 21 cases with clinicopathologic correlation [abstract]. J Invest Dermatol 1991; 96:569A.
35. Nakayama F, Kurosu K, Yumoto N, et al. Immunoglobulin gene analysis of cutaneous pseudolymphoma by polymerase chain reaction. J Dermatol 1995; 22:403-410.
36. Nakayama H, Mihara M, Shimao S. Malignant transformation of lymphadenosis benigna cutis: A possibly transformed case and B- cell lymphoma. Int J Dermatol 1987; 14:266-269.
37. Bindl J, Warnke RAA. Advantage of detecting monoclonal antibody binding to tissue sections with biotin and avidin agents in Coplin jars. Am J Clin Pathol 1986; 85:490-493.
38. Cartun RW, Redersen CA. An immunocytochemical technique offering increased sensitivity and lowered cost with a streptavidin horseradish peroxidase conjugate. J Histotechnol 1989; 12:273- 275.
39. Southern EMA. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98:503-517.
40. Neri A, Jakobiec FA, Pelicci P-G, et al. Immunoglobulin and T cell receptor beta chain gene rearrangement analysis of ocular adnexal lymphoid neoplasms: (Clinical and biological implications. Blood 1987; 70:1519-1529.
41. Turner RR, Egbert P, Warnke PA. Lymphocytic infiltrates of the conjunctiva and orbit: immunohistochemical staining of 16 cases. Am J Clin Pathol 1984; 81:477-452.
42. Weiss LM, Wood GS, Ellisen LW, et al. Clonal T-cell populations in pityriasis lichenoides et varioliformis acuta (Mucha-Habermann disease). Am J Pathol 1987; 126:417-421.
43. Weiss LM, Wood GS, Trela M, et al. Clonal T-cell populations in lymphomatoid papulosis: Evidence for a lymphoproliferative origin for a clinically benign disease. N Engl J Med 1986; 315:475- 479.
44. Wood GS, Weiss LM, Hu C-H, et al. T-cell antigen deficiencies and clonal rearrangements of T-cell receptor genes in pagetoid reticulosis (Woringer-Kolopp disease) N Engl J Med 1988; 318:164-167.
45. McNally L, Jakobiec FA, Knowles 2nd DM. 2nd. Clinical, morphologic, immunophenotypic and molecular genetic analysis of bilateral ocular adnexal lymphoid neoplasms in 17 patients. Am J Ophthalmol 1987; 103:555-568.
46. Chen P, Liu JH, Lin SH, et al. Rearrangement of immunglobulin gene and oncogenes in ocular adnexal pseudolymphomas. Curr Eye Res 1991; 10:547-555.
47. Knowles DM, Athan E, Ubriaco A, et al. Extranodal noncutaneous lymphoid hyperplasias represent a continuous spectrum of B-cell neoplasiai: demonstration by molecular genetic analysis. Blood 1989; 73:1635-1635.
48. Falzon M, Isaacson PG. The natural history of benign lymphoepithelial lesion of the salivary gland in which there is a monoclonal population of B cells. Am J Surg Pathol 1991; 15:59-65.
49. Zulman J, Jaffe R, Talal N. Evidence that the malignant lymphoma of Sjogren's syndrome is a monoclonal B-cell neoplasm. N Engl J Med 1978; 299:1215-1220.
50. Bridges AJ, England MD. Benign lymphoepithelial lesion: relationship to Sjogren's syndrome and evolving malignant lymphoma. Semin Arthritis Rheum 1989; 19:201-208.
51. Azzopardi JG, Evans DL. Malignant lymphoma of parotid associated with Mikulicz disease (benign lymphoepithelial lesion). J Clin Pathol 1971; 24:744-752.
52. Hyman GA, Wolff M. Malignant lymphomas of the salivary glands: Review of the literature and report of 33 new cases, including four cases associated with the lymphoepithelial lesion. Am J Clin Pathol 1976; 65:421-438.
53. Bouloc A, Delfau-Larue MH, Lenormand B, et al. Polymerase chain reaction analysis of immunoglobulin gene rearrangement in cutaneous lymphoid hyperplasias. Arch Dermatol 1999; 135:168-172.
54. Wechsler J, Bagot M, Henni T, et al. Gene analysis in 18 cases of cutaneous lymphoid infiltrates of uncertain significance. Arch Pathol Lab Med 1995; 119:157-162.
55. Dubus P, Vergier B, Beylot-Barry M, et al. Contribution of histopathologic and molecular analyses to the diagnosis of cutaneous B-cell infiltrates. Mod Pathol 1996; 9:1147-1155.
56. Ritter JH, Wick MR, Adesokan PN, et al. Assessment of clonality in cutaneous lymphoid infiltrates by PCR analysis of immunoglobulin heavy chain gene rearrangement. Am J Clin Pathol 1997; 108:60- 68.
57. Rappaport H, (1966) Tumors of the hematopoietic system. Atlas of Tumor Pathology Armed Forces Institute of Pathology, Washington DC.
58. Sepp N, Weyer K, Haun M, et al. Differentiation of primary and secondary cutaneous B-cell lymphoma by Southern blot analysis. Am J Clin Pathol 1996; 106:749-757.
59. Watsky KL, Longley BJ, Dvoretzky L. Primary cutaneous B-cell lymphoma. Diagnosis, treatment and prognosis. J Dermatol Surg Oncol 1992; 18:951-954.
60. Kerl H, Cerrroni L. Primary B-cell lymphomas of the skin. Ann Oncol 1997; 8(Suppl 2):29-32.
61. Kikuchi AA. Treatment of B-cell lymphoma of the skin. Australas J Dermatol 1996; 37(Suppl 1):S34-35.
62. rd ed. W.B. Saunders, Philadelphia pp 1829-1844.
63. Nichols J, Foss F, Kuzel TM, et al. Interleukin-2 fusion protein: An investigational therapy for IL-2 receptor expressing malignancies. Eur J Cancer 1997; 33(Suppl 1):S34-S36.
64. Wollina U. Complete response of a primary cutaneous T-cell-rich B-cell lymphoma treated with interferon alpha-2a. J Cancer Res Clin Oncol 1998; 124:127-129.
65. Nicolaides C, Fountzilas G, Zoumbos N, et al. Diffuse large cell lymphomas: Identification of prognostic factors and validation of the International non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group Study. Oncology 1998; 55:405-415.